Home > Insider Trading > Filing (0001104659-12-032075)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
880771	Sciclone Pharmaceuticals Inc	SCLN	Pharmaceutical Preparations (2834)	943116852

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1163608	Paolo Cavazza	Via Tesserete 10 Lugano V8 00000		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2012-04-30	6,328,469	$5.25	252,469	No	4	S	Indirect	I
Common Stock	Disposition	2012-04-30	252,469	$5.25	0	No	4	D	Indirect	I
Common Stock	Disposition	2012-04-30	252,469	$5.25	513,372	No	4	D	Indirect	I
Common Stock	Disposition	2012-04-30	147,531	$5.25	1,141,521	No	4	D	Indirect	I

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	I
No	4	D	Indirect	I
No	4	D	Indirect	I
No	4	D	Indirect	I

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	822,815	Direct

Footnotes

Shares directly owned by Defiante Farmaceutica S.A. ("Defiante"). Defiante is 58% directly owned by Sigma-Tau Finanziaria S.p.A. ("Sigma-Tau") and 42% directly owned by Sigma-Tau's wholly-owned subsidiary Sigma-Tau International S.A. Paolo Cavazza directly and indirectly owns 38% of Sigma-Tau.
Shares directly owned by Aptafin S.p.A. ("Aptafin"). Aptafin is owned by Paolo Cavazza and members of his family.
Shares directly owned by Sinaf S.A. ("Sinaf"). Sinaf is 100% directly owned by Aptafin.